Antiviral resistance against viral mutation: praxis and policy for SARS-CoV-2

DOI10.1515/CMB-2020-0119MaRDI QIDQ2236688zbMATH OpenOpenAlexFDO

Authors Robert Penner

Publication date 26 October 2021

Published in Computational and Mathematical Biophysics (Search for Journal in Brave)

Copyright license Creative Commons Attribution 4.0 International

Full work available at URL https://doi.org/10.1515/cmb-2020-0119

zbMATH Keywords

mRNA technologystructural biologyvaccinologyvirologyvirus-vector

Mathematics Subject Classification ID

Biochemistry, molecular biology (92C40) Medical epidemiology (92C60)

Recommendations

• Learning the language of viral evolution and escape
• Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
• A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution
• SARS-CoV-2 becoming more infectious as revealed by algebraic topology and deep learning
• The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: a conceptual model for COVID-19

Cited in

(2)

• Learning the language of viral evolution and escape
• Modeling mutation-driven emergence of drug-resistance: a case study of SARS-CoV-2

This page was built for publication: Antiviral resistance against viral mutation: praxis and policy for SARS-CoV-2

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2236688)